Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β(2) Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

INTRODUCTION: In the prospective, observational, 16-week REACT study conducted between October 21, 2008 and May 12, 2011, we compared the real-world effectiveness of anti-inflammatory reliever and maintenance therapy with budesonide/formoterol (Symbicort(®) Turbuhaler) and maintenance therapy with f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shih-Lung, Ho, Ming-Lin, Lai, Yun-Fa, Wang, Hao-Chien, Hsu, Jeng-Yuan, Liu, Shih-Feng, Huang, Ming-Shyang, Lee, Cheng-Hung, Lin, Ching-Hsiung, Hang, Liang-Wen, Liu, Yu-Chih, Yang, Kuang-Yao, Wang, Jia-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733383/
https://www.ncbi.nlm.nih.gov/pubmed/33324041
http://dx.doi.org/10.2147/DDDT.S266177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733383/
https://www.ncbi.nlm.nih.gov/pubmed/33324041
http://dx.doi.org/10.2147/DDDT.S266177

Ejemplares similares